Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model

Journal of Clinical Investigation

Volumn 125, Issue 5, 2015, Pages 2069-2076

  Silva Santos, Sara ^a,b   Van Woerden, Geeske M ^a   Bruinsma, Caroline F ^a   Mientjes, Edwin ^a   Jolfaei, Mehrnoush Aghadavoud ^a   Distel, Ben ^c   Kushner, Steven A ^a   Elgersma, Ype ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PORTO   (Portugal)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE E3A; UNCLASSIFIED DRUG; HYBRID PROTEIN; SYNTHETIC DNA; TAMOXIFEN; UBE3A PROTEIN, MOUSE; UBIQUITIN PROTEIN LIGASE;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN SLICE; COMPULSION; CONTROLLED STUDY; EPILEPSY; FEMALE; HAPPY PUPPET SYNDROME; HIPPOCAMPUS; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; AGE; ANGELMAN SYNDROME; ANIMAL; BIOSYNTHESIS; BRAIN CORTEX; CEREBELLUM; DEFICIENCY; DISEASE MODEL; EMBRYOLOGY; GENE EXPRESSION REGULATION; GENETICS; GENOME IMPRINTING; MALE; MOVEMENT DISORDERS; PATHOPHYSIOLOGY; PHYSIOLOGY; STEREOTYPY;

AGE FACTORS; ANGELMAN SYNDROME; ANIMALS; ANXIETY; CEREBELLUM; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; EPILEPSY; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, SYNTHETIC; GENOMIC IMPRINTING; HIPPOCAMPUS; MALE; MICE; MOVEMENT DISORDERS; NEURONAL PLASTICITY; PHENOTYPE; RECOMBINANT FUSION PROTEINS; STEREOTYPED BEHAVIOR; TAMOXIFEN; UBIQUITIN-PROTEIN LIGASES;

EID: 84929018021     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI80554     Document Type: Article

References (25)

1. Williams CA. Neurological aspects of the Angelman syndrome. Brain Dev. 2005;27(2):88-94.
2. Rougeulle C, Cardoso C, Fontés M, Colleaux L, Lalande M. An imprinted antisense RNA overlaps UBE3A and a second maternally expressed transcript. Nat Genet. 1998;19(1):15-16.
3. Meng L, Person RE, Huang W, Zhu PJ, Costa-Mattioli M, Beaudet AL. Truncation of Ube3a-ATS unsilences paternal Ube3a and ameliorates behavioral defects in the Angelman syndrome mouse model. PLoS Genet. 2013;9(12):e1004039.
4. Meng L, Person RE, Beaudet AL. Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a. Hum Mol Genet. 2012;21(13):3001-3012.
5. Mabb AM, Judson MC, Zylka MJ, Philpot BD. Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes. Trends Neurosci. 2011;34(6):293-303.
6. Beaudet AL. Angelman syndrome: drugs to awaken a paternal gene. Nature. 2012;481(7380):150-152.
7. Huang HS, et al. Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons. Nature. 2012;481(7380):185-189.
8. Meng L, Ward AJ, Chun S, Bennett CF, Beaudet AL, Rigo F. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA. Nature. 2015;518(7539):409-412.
9. Meredith RM, Dawitz J, Kramvis I. Sensitive time-windows for susceptibility in neurodevelopmental disorders. Trends Neurosci. 2012;35(6):335-344.
10. Suri D, Teixeira CM, Cagliostro MKC, Mahadevia D, Ansorge MS. Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors. Neuropsychopharmacology. 2015;40(1):88-112.
11. Guy J, Gan J, Selfridge J, Cobb S, Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science. 2007;315(5815):1143-1147.
12. Clement JP, et al. Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses. Cell. 2012;151(4):709-723.
13. Sakai K, Miyazaki JI. A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission. Biochem Biophys Res Commun. 1997;237(2):318-324.
14. Huang HS, et al. Behavioral deficits in an Angelman syndrome model: effects of genetic background and age. Behav Brain Res. 2013;243:79-90.
15. Jiang YH, et al. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and longterm potentiation. Neuron. 1998;21(4):799-811.
16. van Woerden GM, et al. Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of alphaCaMKII inhibitory phosphorylation. Nat Neurosci. 2007;10(3):280-282.
17. Hayashi S, McMahon AP. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol. 2002;244(2):305-318.
18. Kaphzan H, et al. Reversal of impaired hippocampal long-term potentiation and contextual fear memory deficits in Angelman syndrome model mice by ErbB inhibitors. Biol Psychiatry. 2012;72(3):182-190.
19. Baudry M, et al. Ampakines promote spine actin polymerization, long-term potentiation, and learning in a mouse model of Angelman syndrome. Neurobiol Dis. 2012;47(2):210-215.
20. Daily JL, et al. Adeno-associated virus-mediated rescue of the cognitive defects in a mouse model for Angelman syndrome. PLoS One. 2011;6(12):e27221.
21. Bhattacharya A, Klann E. Fragile X syndrome therapeutics S(C)TEP through the developmental window. Neuron. 2012;74(1):1-3.
22. Koike H, Arguello PA, Kvajo M, Karayiorgou M, Gogos JA. Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice. Proc Natl Acad Sci U S A. 2006;103(10):3693-3697.
23. Clapcote SJ, et al. Behavioral phenotypes of Disc1 missense mutations in mice. Neuron. 2007;54(3):387-402.
24. Workman AD, Charvet CJ, Clancy B, Darlington RB, Finlay BL. Modeling transformations of neurodevelopmental sequences across mammalian species. J Neurosci. 2013;33(17):7368-7383.
25. Levelt CN, Hübener M. Critical-period plasticity in the visual cortex. Annu Rev Neurosci. 2012;35:309-330.